Longeveron Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Longeveron Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 991% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 90% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-22.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 59% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-2% / -63%In 3 years sales changed by -2% while total assets changed by -63%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-28.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 62% of Healthcare companies in United States.
Cash Cushion Ratio
+76%Cash, after subtracting all debt, equals 76% of its market value (net cash).
Higher than 84% of Healthcare companies in United States.
Tangible Assets Ratio
78%Of every $100 the company owns, $78 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 54% of Healthcare companies in United States.
Tangible Net Worth Ratio
60%Of every $100 of net worth, $60 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 52% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Longeveron Inc. made a loss over the last year. Longeveron Inc. owes $0.33 for every $1 it owns. Longeveron Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossLongeveron Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.49The share price is 0.49 times Longeveron Inc.'s book value per share, lower than 91% of Healthcare companies in United States.
Market cap
$5 MThe total market value of all of Longeveron Inc.'s shares at today's price (share price × number of shares), smaller than 93% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$10 MWhat Longeveron Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.26Net worth divided by the number of shares. The share price of $1.60 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-203.6%Longeveron Inc. lost 203.6% of its shareholders' money over the last year, lower than 85% of Healthcare companies in United States.
Owes vs Owns
0.33×Longeveron Inc. owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Dividend yield
NoneLongeveron Inc. does not currently pay a dividend.
Revenue growth
-50%Revenue fell 50% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Profit growth
LossLongeveron Inc. made a loss in each of the last two years.
Profit margin
-1893.6%Longeveron Inc. lost $1894 for every $100 of revenue.
Cash vs debt
Net cashLongeveron Inc. held $4 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Longeveron Inc.: $5 M ÷ $10 M (30 Jun 2026) = 0.5.
What is Longeveron Inc.'s return on equity?
Longeveron Inc. lost 203.6% of its shareholders' money over the last year, lower than 85% of Healthcare companies in United States.
How much does Longeveron Inc. owe compared with what it owns?
Longeveron Inc. owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Does Longeveron Inc. pay a dividend?
No. Longeveron Inc. does not currently pay a dividend.
Is Longeveron Inc.'s revenue growing?
Revenue fell 50% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.